Fundraising Fox
/Companies
Sign in

Adcentrx Therapeutics

Founded 2021 · 20 employees on LinkedIn · 7 known investors

Find your way into Adcentrx Therapeutics

Sign up to see every warm intro you have to Adcentrx Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Adcentrx Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Adcentrx Therapeutics is a biotech company focused on the discovery and clinical development of antibody-drug conjugates (ADCs) for oncology. It develops site-specific ADC therapeutics and supporting platform technology for cancer treatment.

BiotechHealthtech

Founders & leadership

HLHui Li
Hui LiPresident & CEOHui Li holds a PhD in Chemistry from UC San Diego and brings over 20 years of experience in the life sciences industry, including work in biotechnology and pharmaceutical development. As Founder, President and CEO of Adcentrx Therapeutics, he leads efforts in antibody-drug conjugate discovery and development for oncology.

Investors · 7

F-Prime Capitallisted by F-Prime CapitalCambridge · $3M – $10M

How we know: F-Prime Capital's portfolio page · pharmaceutical-technology.com · Not right? Tell us

Quan Capitallisted by Quan CapitalShanghai

How we know: Quan Capital's portfolio page · funding news · adcentrx.com · Not right? Tell us

Delta CapitalreportedSantana De Parnaiba

How we know: pharmaceutical-technology.com · Not right? Tell us

Also in the syndicate · 3

ABio-XPartners InvestmentTrinity Innovation Fund

Funding

SEC filings, press & company announcements

$38M disclosed across 1 of 2 rounds · 2023

Source: company announcements and press reports — follow each round's link for the claim.

Related companies · 3

Addex TherapeuticsAddex Therapeutics is a clinical-stage pharmaceutical company that develops orally available small molecule drugs known as allosteric modulators for neurological disorders.
BioworldBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
AlumniAstraZeneca develops and markets pharmaceutical products, vaccines, and biologics across oncology, cardiovascular disease, respiratory and immunology, and rare disease areas, serving patients and healthcare providers globally.

Companies working in the same space as Adcentrx Therapeutics.

In the news

Adcentrx Announces Extension of Series A+ Financing to $51 Million - Adcentrx Therapeuticsadcentrx.com · Dec 2023Adcentrx Therapeutics Announces Completion of $38 million Series A+ Financing Led by Eight Roads Ventures - Adcentrx Therapeuticsadcentrx.com · Apr 2023

Frequently asked questions

What does Adcentrx Therapeutics do?
Adcentrx Therapeutics is a biotech company focused on the discovery and clinical development of antibody-drug conjugates (ADCs) for oncology. It develops site-specific ADC therapeutics and supporting platform technology for cancer treatment.
Who are Adcentrx Therapeutics's investors?
Adcentrx Therapeutics's investors include Eight Roads Ventures, F-Prime Capital, Quan Capital, Delta Capital.
How much funding has Adcentrx Therapeutics raised?
Adcentrx Therapeutics has disclosed $38M raised across 1 of its 2 known rounds.